Implications of Fentanyl Scheduling on Medical Research

This chapter explores the complexities of classifying drugs like fentanyl as Schedule 1 and how it hampers medical research. The speakers discuss the implications for pharmaceutical companies and the potential risks to innovative therapeutic advancements due to stringent regulations.